British Journal of Cancer
(BRIT J CANCER) 《英国癌症杂志》
2012年影响因子
5.082
- 2012-11-01•低渗性SNP对乳腺癌风险的综合作用
- 2012-08-30•卵巢癌试验可将CA-125纳入肿瘤评估标准：GCIG CALYPSO试验的经验
- 2012-07-25•让艰难选择变轻松：一项旨在评估生育相关决策辅助对年轻早期乳腺癌女性患者的影响的前瞻性多中心研究
- 2012-08-19•TNFα 附近多态性和放疗不良反应风险复制联系
- 2012-08-19•口腔癌中miR-126下调可通过VEGF-A活化诱发血管形成和淋巴管形成
最新一期
Clinical Studies
A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications
P G Corrie, R Bulusu, C B Wilson, G Armstrong, S Bond, R Hardy, S Lao-Sirieix, D Parashar, A Ahmad, F Daniel, M Hill, G Wilson, C Blesing, A M Moody, K McAdam and M Osborne
Br J Cancer 107: 585-587; advance online publication, July 19, 2012; doi:10.1038/bjc.2012.318
Abstract | Full Text | PDF
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients FREE
U Wagner, C Marth, R Largillier, J Kaern, C Brown, M Heywood, T Bonaventura, I Vergote, M C Piccirillo, R Fossati, V Gebski and E P Lauraine
Br J Cancer 107: 588-591; advance online publication, July 26, 2012; doi:10.1038/bjc.2012.307
Abstract | Full Text | PDF
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer
C Nabhan, D Villines, T V Valdez, K Tolzien, T M Lestingi, J D Bitran, S M Christner, M J Egorin and J H Beumer
Br J Cancer 107: 592-597; advance online publication, July 17, 2012; doi:10.1038/bjc.2012.312
Abstract | Full Text | PDF
Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours
G Freyer, N Isambert, B You, S Zanetta, C Falandry, L Favier, V Trillet-Lenoir, S Assadourian, K Soussan-Lazard, S Ziti-Ljajic and P Fumoleau
Br J Cancer 107: 598-603; advance online publication, July 12, 2012; doi:10.1038/bjc.2012.304
Abstract | Full Text | PDF
A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
I Diaz-Padilla, L L Siu, M San Pedro-Salcedo, A R A Razak, A D Colevas, F A Shepherd, N B Leighl, J W Neal, A Thibault, L Liu, J Lisano, B Gao, E B Lawson and H A Wakelee
Br J Cancer 107: 604-611; advance online publication, July 17, 2012; doi:10.1038/bjc.2012.319
Abstract | Full Text | PDF
Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies
M Mandalà, F Grosso, C Vitalini, I Corradino, R Sanfilippo, S Colombini, M Clerici, R Labianca, A De Pascale and S Marsoni
Br J Cancer 107: 612-616; advance online publication, July 24, 2012; doi:10.1038/bjc.2012.325
Abstract | Full Text | PDF
Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage
L E Carlson, A Waller, S L Groff, L Zhong and B D Bultz
Br J Cancer 107: 617-625; advance online publication, July 24, 2012; doi:10.1038/bjc.2012.309
Abstract | Full Text | PDF | Supplementary information
KRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer
U Malapelle, C Carlomagno, M Salatiello, A De Stefano, C De Luca, R Bianco, R Marciano, C Cimminiello, C Bellevicine, S De Placido and G Troncone
Br J Cancer 107: 626-631; advance online publication, July 17, 2012; doi:10.1038/bjc.2012.275
Abstract | Full Text | PDF
Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer
K Kaira, Y Sunose, K Arakawa, T Ogawa, N Sunaga, K Shimizu, H Tominaga, N Oriuchi, H Itoh, S Nagamori, Y Kanai, A Segawa, M Furuya, M Mori, T Oyama and I Takeyoshi
Br J Cancer 107: 632-638; advance online publication, July 17, 2012; doi:10.1038/bjc.2012.310
Abstract | Full Text | PDF | Supplementary information
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study
S Sleijfer, T Gorlia, C Lamers, H Burger, J-Y Blay, A Le Cesne, M Scurr, F Collin, L Pandite, S Marreaud and P Hohenberger
Br J Cancer 107: 639-645; advance online publication, July 17, 2012; doi:10.1038/bjc.2012.328
Abstract | Full Text | PDF
Effect of Paget’s disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis Open
S-M Tu, A Som, B Tu, C J Logothetis, M-H Lee and S-CJ Yeung
Br J Cancer 107: 646-651; advance online publication, July 17, 2012; doi:10.1038/bjc.2012.315
Abstract | Full Text | PDF
Translational Therapeutics
Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer
N Kozakai, E Kikuchi, M Hasegawa, E Suzuki, H Ide, A Miyajima, Y Horiguchi, J Nakashima, K Umezawa, N Shigematsu and M Oya
Br J Cancer 107: 652-657; advance online publication, July 17, 2012; doi:10.1038/bjc.2012.321
Abstract | Full Text | PDF
Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice
Y Edrei, E Gross, N Corchia and R Abramovitch
Br J Cancer 107: 658-666; advance online publication, July 17, 2012; doi:10.1038/bjc.2012.322
Abstract | Full Text | PDF | Supplementary information
Molecular Diagnostics
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer
K Boye, J M Nesland, B Sandstad, M Haugland Haugen, G M Mælandsmo and K Flatmark
Br J Cancer 107: 667-674; advance online publication, July 10, 2012; doi:10.1038/bjc.2012.293
Abstract | Full Text | PDF | Supplementary information
Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome Open
Y-Q Zhang, M Pilyugin, D Kuester, V P Leoni, L Li, G Casula, L Zorcolo, R Schneider-Stock, L Atzori and I Irminger-Finger
Br J Cancer 107: 675-683; advance online publication, July 19, 2012; doi:10.1038/bjc.2012.297
Abstract | Full Text | PDF | Supplementary information
Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation
J S Hall, J Taylor, H R Valentine, J J Irlam, A Eustace, P J Hoskin, C J Miller and C M L West
Br J Cancer 107: 684-694; advance online publication, July 17, 2012; doi:10.1038/bjc.2012.294
Abstract | Full Text | PDF | Supplementary information
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
M J Proctor, D C McMillan, D S Morrison, C D Fletcher, P G Horgan and S J Clarke
Br J Cancer 107: 695-699; advance online publication, July 24, 2012; doi:10.1038/bjc.2012.292
Abstract | Full Text | PDF
Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer FREE
T Sasahira, M Kurihara, U K Bhawal, N Ueda, T Shimomoto, K Yamamoto, T Kirita and H Kuniyasu
Br J Cancer 107: 700-706; advance online publication, July 26, 2012; doi:10.1038/bjc.2012.330
Abstract | Full Text | PDF
Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies
M A St John, G Wang, J Luo, M Dohadwala, D Hu, Y Lin, M Dennis, J M Lee, D Elashoff, T Lawhon, S L Zaknoen, F J Burrows and S M Dubinett
Br J Cancer 107: 707-712; advance online publication, July 24, 2012; doi:10.1038/bjc.2012.203
Abstract | Full Text | PDF
Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrinβ3 affinity modulation
A Goc, J Liu, T V Byzova and P R Somanath
Br J Cancer 107: 713-723; advance online publication, July 5, 2012; doi:10.1038/bjc.2012.295
Abstract | Full Text | PDF | Supplementary information
Accurate and rapid novel genetic diagnosis for detection of sentinel lymph node metastasis in breast cancer patients
H Iinuma, J Tamura, D Omoto, N Kamo, S Ohnaka, Y Mitoma, Y Miyazawa, K Okinaga, T Imamura, R Fukushima, T Watanabe and T Ikeda
Br J Cancer 107: 724-731; advance online publication, July 10, 2012; doi:10.1038/bjc.2012.300
Abstract | Full Text | PDF | Supplementary information
Genetics and Genomics
Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse
C Palmieri, M Monteverde, L Lattanzio, O Gojis, B Rudraraju, M Fortunato, N Syed, A Thompson, O Garrone, M Merlano, C Lo Nigro and T Crook
Br J Cancer 107: 732-738; advance online publication, July 10, 2012; doi:10.1038/bjc.2012.308
Abstract | Full Text | PDF
Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the non-catalytic C terminus
S A Carter, N A Foster, C G Scarpini, A Chattopadhyay, M R Pett, I Roberts and N Coleman
Br J Cancer 107: 739-747; advance online publication, July 10, 2012; doi:10.1038/bjc.2012.301
Abstract | Full Text | PDF | Supplementary information
A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy FREE
C J Talbot, G A Tanteles, G C Barnett, N G Burnet, J Chang-Claude, C E Coles, S Davidson, A M Dunning, J Mills, R J S Murray, O Popanda, P Seibold, C M L West, J R Yarnold and R P Symonds
Br J Cancer 107: 748-753; advance online publication, July 5, 2012; doi:10.1038/bjc.2012.290
Abstract | Full Text | PDF
Letter to the Editor
Comment on ‘Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies’
D Lightsey National Council Against Health Fraud and Quackwatch
Br J Cancer 107: 754-755; advance online publication, July 17, 2012; doi:10.1038/bjc.2012.111
Full Text | PDF
Corrigendum
Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor negative breast cancer FREE
J Ohotski, J S Long, C Orange, B Elsberger, E Mallon, J Doughty, S Pyne, N J Pyne and J Edwards
Br J Cancer 107: 756; doi:10.1038/bjc.2012.352
Full Text | PDF
